Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication
Open Access
- 30 November 2010
- journal article
- Published by Elsevier BV in Clinical Gastroenterology and Hepatology
- Vol. 8 (11), 972-978
- https://doi.org/10.1016/j.cgh.2010.07.012
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Hepatitis C treatment completion rates in routine clinical careLiver International, 2009
- Clinical Case Registries: Simultaneous Local and National Disease Registries for Population Quality ManagementJournal of the American Medical Informatics Association, 2009
- Treatment Outcomes With Pegylated Interferon and Ribavirin for Male Prisoners With Chronic Hepatitis CJournal of Clinical Gastroenterology, 2009
- Psychiatric symptoms during interferon treatment for hepatitis C:experiences from a tertiary care hepatology centreAlimentary Pharmacology & Therapeutics, 2008
- Predictors of response of U.S. veterans to treatment for the hepatitis C virusHepatology, 2007
- Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patientsAIDS Care, 2007
- The Prevalence of Hepatitis C Virus Infection in the United States, 1999 through 2002Annals of Internal Medicine, 2006
- Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practiceAlimentary Pharmacology & Therapeutics, 2006
- Elevated prevalence of hepatitis C infection in users of United States veterans medical centersHepatology, 2004
- Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis CGastroenterology, 2002